# |
|
Family |
MCID |
Name |
MIFTS |
Score |
1 |
|
P
|
GLM015 |
Glomerulopathy with Fibronectin Deposits 2 |
30 |
8.905 |
|
2 |
|
|
LPP002 |
Lipoprotein Glomerulopathy |
44 |
5.891 |
|
3 |
|
c
|
GLM014 |
Glomerulopathy with Fibronectin Deposits 1 |
18 |
5.363 |
|
4 |
|
|
FBR085 |
Fibrillary Glomerulonephritis |
23 |
4.178 |
|
5 |
|
c
|
CNG407 |
Congenital Membranous Nephropathy Due to Maternal Anti-Neutral Endopeptidase Alloimmunization |
10 |
3.995 |
|
6 |
|
|
CLL035 |
Collagen Type Iii Glomerulopathy |
12 |
3.654 |
|
7 |
|
|
IMM053 |
Immunotactoid Glomerulopathy |
23 |
3.395 |
|
8 |
|
|
IMM051 |
Immunotactoid or Fibrillary Glomerulopathy |
12 |
3.083 |
|
9 |
|
|
C3G002 |
C3 Glomerulopathy |
34 |
2.611 |
|
10 |
|
|
NNM007 |
Non-Immunoglobulin-Mediated Membranoproliferative Glomerulonephritis |
16 |
2.566 |
|
11 |
|
|
MSN011 |
Mesangioproliferative Glomerulopathy |
5 |
2.131 |
|
12 |
|
|
OCL043 |
Oculorenocerebellar Syndrome |
20 |
2.057 |
|
13 |
|
|
SPR078 |
Sporadic Idiopathic Steroid-Resistant Nephrotic Syndrome with Collapsing Glomerulopathy |
4 |
2.057 |
|
14 |
|
|
LPD004 |
Lipoid Nephrosis |
46 |
1.998 |
|
15 |
|
P
|
GLM007 |
Glomerulonephritis |
61 |
0.240 |
|
16 |
|
P
|
NPH012 |
Nephrotic Syndrome |
60 |
0.186 |
|
17 |
|
|
DNS007 |
Dense Deposit Disease |
36 |
0.157 |
|
18 |
|
P
|
KDN018 |
Kidney Disease |
69 |
0.152 |
|
19 |
|
|
MMB001 |
Membranoproliferative Glomerulonephritis |
51 |
0.122 |
|
20 |
|
P
|
HPT021 |
Hepatitis |
75 |
0.107 |
|
21 |
|
|
ATM095 |
Autoimmune Disease |
66 |
0.099 |
|
22 |
|
P
|
HML001 |
Hemolytic-Uremic Syndrome |
50 |
0.099 |
|
23 |
|
P
|
LYM118 |
Lymphoma |
71 |
0.091 |
|
24 |
|
P
|
AMY004 |
Amyloidosis |
69 |
0.091 |
|
25 |
|
P
|
ANR048 |
Aniridia 1 |
68 |
0.091 |
|
26 |
|
P
|
CRY007 |
Cryoglobulinemia, Familial Mixed |
49 |
0.091 |
|
27 |
|
|
ANR038 |
Anorexia Nervosa 1 |
21 |
0.091 |
|
28 |
|
|
BLD137 |
Blood Group--Ahonen |
17 |
0.091 |
|
29 |
|
P
|
LKM002 |
Leukemia |
75 |
0.081 |
|
30 |
|
|
ALP046 |
Alport Syndrome, X-Linked |
74 |
0.081 |
|
31 |
|
|
SCK003 |
Sickle Cell Anemia |
73 |
0.081 |
|
32 |
|
c
|
HPT001 |
Hepatitis C |
73 |
0.081 |
|
33 |
|
P
|
LPS004 |
Lupus Erythematosus |
69 |
0.081 |
|
34 |
|
|
CNN005 |
Connective Tissue Disease |
65 |
0.081 |
|
35 |
|
|
ALP042 |
Alpha/beta T-Cell Lymphopenia with Gamma/delta T-Cell Expansion, Severe Cytomegalovirus Infection, and Autoimmunity |
63 |
0.081 |
|
36 |
|
|
URN009 |
Urinary System Disease |
58 |
0.081 |
|
37 |
|
P
|
MMB011 |
Membranous Nephropathy |
55 |
0.081 |
|
38 |
|
P
|
HML033 |
Hemolytic Uremic Syndrome, Atypical 1 |
49 |
0.081 |
|
39 |
|
|
END072 |
Endotheliitis |
46 |
0.081 |
|
40 |
|
c
|
BLD140 |
Blood Group, I System |
37 |
0.081 |
|
41 |
|
P
|
ART153 |
Arthrochalasia Ehlers-Danlos Syndrome |
21 |
0.081 |
|
42 |
|
c
|
SYS001 |
Systemic Lupus Erythematosus |
86 |
0.070 |
|
43 |
|
|
BDY004 |
Body Mass Index Quantitative Trait Locus 11 |
75 |
0.070 |
|
44 |
|
P
|
DBT009 |
Diabetes Mellitus |
72 |
0.070 |
|
45 |
|
P
|
BCL006 |
B-Cell Lymphomas |
70 |
0.070 |
|
46 |
|
|
VSC011 |
Vasculitis |
66 |
0.070 |
|
47 |
|
P
|
HYP098 |
Hypereosinophilic Syndrome |
65 |
0.070 |
|
48 |
|
|
AGN016 |
Aging |
65 |
0.070 |
|
49 |
|
P
|
FCL005 |
Focal Segmental Glomerulosclerosis |
60 |
0.070 |
|
50 |
|
|
END030 |
End Stage Renal Failure |
59 |
0.070 |
|
51 |
|
c
|
FCL025 |
Focal Segmental Glomerulosclerosis 1 |
59 |
0.070 |
|
52 |
|
P
|
LPD010 |
Lipodystrophy |
57 |
0.070 |
|
53 |
|
P
|
SYP003 |
Syphilis |
55 |
0.070 |
|
54 |
|
|
MTC114 |
Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-Like Episodes |
55 |
0.070 |
|
55 |
|
|
RTN023 |
Retinitis |
52 |
0.070 |
|
56 |
|
|
FRS002 |
Frasier Syndrome |
51 |
0.070 |
|
57 |
|
|
HYP806 |
Hypertension, Early-Onset, Autosomal Dominant, with Severe Exacerbation in Pregnancy |
51 |
0.070 |
|
58 |
|
|
CRY004 |
Cryoglobulinemia |
49 |
0.070 |
|
59 |
|
|
BDY005 |
Body Mass Index Quantitative Trait Locus 9 |
49 |
0.070 |
|
60 |
|
|
BDY019 |
Body Mass Index Quantitative Trait Locus 18 |
48 |
0.070 |
|
61 |
|
|
BDY017 |
Body Mass Index Quantitative Trait Locus 14 |
46 |
0.070 |
|
62 |
|
|
BDY015 |
Body Mass Index Quantitative Trait Locus 12 |
46 |
0.070 |
|
63 |
|
|
BDY010 |
Body Mass Index Quantitative Trait Locus 4 |
45 |
0.070 |
|
64 |
|
|
BDY011 |
Body Mass Index Quantitative Trait Locus 10 |
45 |
0.070 |
|
65 |
|
|
BDY006 |
Body Mass Index Quantitative Trait Locus 8 |
42 |
0.070 |
|
66 |
|
|
BDY012 |
Body Mass Index Quantitative Trait Locus 7 |
42 |
0.070 |
|
67 |
|
c
|
CNG033 |
Congenital Syphilis |
40 |
0.070 |
|
68 |
|
|
CMP042 |
Complement Factor H Deficiency |
39 |
0.070 |
|
69 |
|
|
ALR002 |
Al-Raqad Syndrome |
30 |
0.070 |
|
70 |
|
P
|
WSK001 |
Wiskott-Aldrich Syndrome |
76 |
0.057 |
|
71 |
|
P
|
LVR013 |
Liver Disease |
76 |
0.057 |
|
72 |
|
|
MYC006 |
Mycosis Fungoides |
73 |
0.057 |
|
73 |
|
c
|
HPT073 |
Hepatitis C Virus |
73 |
0.057 |
|
74 |
|
P
|
GRF003 |
Graft-Versus-Host Disease |
72 |
0.057 |
|
75 |
|
|
FBR012 |
Fabry Disease |
72 |
0.057 |
|
76 |
|
|
NRF026 |
Neurofibromatosis, Type Iv, of Riccardi |
72 |
0.057 |
|
77 |
|
|
WGN006 |
Wegener Granulomatosis |
71 |
0.057 |
|
78 |
|
|
DWN001 |
Down Syndrome |
70 |
0.057 |
|
79 |
|
|
BHC003 |
Behcet Syndrome |
68 |
0.057 |
|
80 |
|
P
|
PRD006 |
Prader-Willi Syndrome |
66 |
0.057 |
|
81 |
|
P
|
PSR002 |
Psoriasis |
65 |
0.057 |
|
82 |
|
c
|
CHR417 |
Chronic Graft Versus Host Disease |
65 |
0.057 |
|
83 |
|
|
DFF005 |
Diffuse Large B-Cell Lymphoma |
64 |
0.057 |
|
84 |
|
P
|
CCK001 |
Cockayne Syndrome |
64 |
0.057 |
|
85 |
|
P
|
ESP024 |
Esophagitis |
64 |
0.057 |
|
86 |
|
P
|
NRP001 |
Neuropathy |
63 |
0.057 |
|
87 |
|
c
|
NRF024 |
Neurofibromatosis, Type I |
63 |
0.057 |
|
88 |
|
|
LWC002 |
Lowe Oculocerebrorenal Syndrome |
62 |
0.057 |
|
89 |
|
|
LCT022 |
Lecithin:cholesterol Acyltransferase Deficiency |
61 |
0.057 |
|
90 |
|
|
MCR088 |
Microscopic Polyangiitis |
58 |
0.057 |
|
91 |
|
P
|
NRP054 |
Neuropathy, Hereditary Sensory and Autonomic, Type Iii |
57 |
0.057 |
|
92 |
|
|
HYP810 |
Hypereosinophilic Syndrome, Idiopathic |
57 |
0.057 |
|
93 |
|
|
IMM136 |
Immune System Disease |
57 |
0.057 |
|
94 |
|
|
CYT008 |
Cytomegalovirus Infection |
57 |
0.057 |
|
95 |
|
|
RTN018 |
Retinal Disease |
56 |
0.057 |
|
96 |
|
|
NLP001 |
Nail-Patella Syndrome |
56 |
0.057 |
|
97 |
|
|
ALS001 |
Alstrom Syndrome |
55 |
0.057 |
|
98 |
|
|
RLP001 |
Relapsing Polychondritis |
55 |
0.057 |
|
99 |
|
|
GDP001 |
Goodpasture Syndrome |
55 |
0.057 |
|
100 |
|
c
|
LPD015 |
Lipodystrophy, Familial Partial, Type 2 |
55 |
0.057 |
|
101 |
|
|
ESP020 |
Esophageal Atresia |
54 |
0.057 |
|
102 |
|
|
IGG001 |
Iga Glomerulonephritis |
52 |
0.057 |
|
103 |
|
c
|
MLG069 |
Malignant Hypertension |
49 |
0.057 |
|
104 |
|
|
ESN020 |
Eosinophilic Granulomatosis with Polyangiitis |
47 |
0.057 |
|
105 |
|
|
SCH016 |
Schimke Immunoosseous Dysplasia |
47 |
0.057 |
|
106 |
|
|
LGH004 |
Light Chain Deposition Disease |
47 |
0.057 |
|
107 |
|
|
RNL051 |
Renal Cysts and Diabetes Syndrome |
45 |
0.057 |
|
108 |
|
P
|
GLL032 |
Galloway-Mowat Syndrome |
45 |
0.057 |
|
109 |
|
|
PSD009 |
Pseudohermaphroditism |
42 |
0.057 |
|
110 |
|
P
|
HVY001 |
Heavy Chain Disease |
41 |
0.057 |
|
111 |
|
|
DBT090 |
Diabetes and Deafness, Maternally Inherited |
40 |
0.057 |
|
112 |
|
|
BLL012 |
Bullous Impetigo |
40 |
0.057 |
|
113 |
|
c
|
PSR018 |
Psoriasis 13 |
39 |
0.057 |
|
114 |
|
c
|
LPD019 |
Lipodystrophy, Partial, Acquired |
38 |
0.057 |
|
115 |
|
|
HYP193 |
Hypocomplementemic Urticarial Vasculitis |
38 |
0.057 |
|
116 |
|
|
ALP041 |
Alopecia, Neurologic Defects, and Endocrinopathy Syndrome |
37 |
0.057 |
|
117 |
|
c
|
GLL038 |
Galloway-Mowat Syndrome 1 |
37 |
0.057 |
|
118 |
|
c
|
TYP024 |
Type Ii Mixed Cryoglobulinemia |
36 |
0.057 |
|
119 |
|
|
MJD001 |
Majeed Syndrome |
35 |
0.057 |
|
120 |
|
P
|
IGN003 |
Iga Nephropathy 1 |
34 |
0.057 |
|
121 |
|
|
IMM073 |
Immunoglobulin a Vasculitis |
28 |
0.057 |
|
122 |
|
|
ALP085 |
Alport Syndrome-Intellectual Disability-Midface Hypoplasia-Elliptocytosis Syndrome |
21 |
0.057 |
|
123 |
|
|
NPH023 |
Nephropathy, Deafness, and Hyperparathyroidism |
18 |
0.057 |
|
124 |
|
|
NLP003 |
Nail-Patella-Like Renal Disease |
16 |
0.057 |
|
125 |
|
|
IMM160 |
Immune Response to Synthetic Polypeptide--Irtgal |
9 |
0.057 |
|
126 |
|
|
MYL069 |
Myeloma, Multiple |
86 |
0.041 |
|
127 |
|
|
MLR004 |
Malaria |
86 |
0.041 |
|
128 |
|
P
|
MLT020 |
Multiple Sclerosis |
85 |
0.041 |
|
129 |
|
|
STR067 |
Stroke, Ischemic |
84 |
0.041 |
|
130 |
|
P
|
HYP607 |
Hypercholesterolemia, Familial |
81 |
0.041 |
|
131 |
|
c
|
MCL042 |
Macular Degeneration, Age-Related, 1 |
79 |
0.041 |
|
132 |
|
|
LYM133 |
Lymphoma, Hodgkin, Classic |
78 |
0.041 |
|
133 |
|
P
|
MYL005 |
Myelofibrosis |
75 |
0.041 |
|
134 |
|
c
|
LKM071 |
Leukemia, Chronic Lymphocytic |
75 |
0.041 |
|
135 |
|
P
|
FML018 |
Familial Mediterranean Fever |
73 |
0.041 |
|
136 |
|
|
BRC012 |
Brucellosis |
71 |
0.041 |
|
137 |
|
|
LYM143 |
Lymphoma, Non-Hodgkin, Familial |
71 |
0.041 |
|
138 |
|
|
SMT004 |
Smith-Lemli-Opitz Syndrome |
70 |
0.041 |
|
139 |
|
P
|
AGM001 |
Agammaglobulinemia |
70 |
0.041 |
|
140 |
|
P
|
AGM019 |
Agammaglobulinemia, X-Linked |
69 |
0.041 |
|
141 |
|
P
|
MYC084 |
Mycobacterium Tuberculosis 1 |
69 |
0.041 |
|
142 |
|
|
LYM017 |
Lyme Disease |
68 |
0.041 |
|
143 |
|
|
SRC014 |
Sarcoma |
68 |
0.041 |
|
144 |
|
P
|
CHR071 |
Charcot-Marie-Tooth Disease |
67 |
0.041 |
|
145 |
|
|
MXD005 |
Mixed Connective Tissue Disease |
66 |
0.041 |
|
146 |
|
|
PCK003 |
Pick Disease of Brain |
66 |
0.041 |
|
147 |
|
|
ADL030 |
Adult-Onset Still's Disease |
65 |
0.041 |
|
148 |
|
|
TNG002 |
Tangier Disease |
65 |
0.041 |
|
149 |
|
P
|
PRX003 |
Paroxysmal Nocturnal Hemoglobinuria |
64 |
0.041 |
|
150 |
|
|
ABT001 |
Abetalipoproteinemia |
64 |
0.041 |
|
151 |
|
|
PMS001 |
Poems Syndrome |
64 |
0.041 |
|
152 |
|
|
SVR066 |
Severe Combined Immunodeficiency, X-Linked |
63 |
0.041 |
|
153 |
|
|
HMR004 |
Hemorrhagic Fever with Renal Syndrome |
63 |
0.041 |
|
154 |
|
P
|
CTS001 |
Cutis Laxa |
62 |
0.041 |
|
155 |
|
|
THR024 |
Thrombosis |
61 |
0.041 |
|
156 |
|
|
HYP266 |
Hypoxia |
61 |
0.041 |
|
157 |
|
|
HYP190 |
Hypoalphalipoproteinemia, Primary |
61 |
0.041 |
|
158 |
|
|
DNH001 |
Donohue Syndrome |
60 |
0.041 |
|
159 |
|
P
|
HMR012 |
Hemorrhagic Fever |
60 |
0.041 |
|
160 |
|
|
ATH013 |
Atherosclerosis Susceptibility |
59 |
0.041 |
|
161 |
|
P
|
HYP724 |
Hyperlipoproteinemia, Type Iii |
59 |
0.041 |
|
162 |
|
P
|
EPD009 |
Epidermolysis Bullosa Dystrophica |
59 |
0.041 |
|
163 |
|
|
LPD008 |
Lipid Metabolism Disorder |
59 |
0.041 |
|
164 |
|
|
CRT016 |
Carotid Artery Disease |
58 |
0.041 |
|
165 |
|
P
|
END033 |
Endocarditis |
58 |
0.041 |
|
166 |
|
|
GLC003 |
Glucose Intolerance |
58 |
0.041 |
|
167 |
|
P
|
HYP614 |
Hyperlipidemia, Familial Combined |
57 |
0.041 |
|
168 |
|
|
INF034 |
Infective Endocarditis |
56 |
0.041 |
|
169 |
|
|
ACR008 |
Acrocallosal Syndrome |
56 |
0.041 |
|
170 |
|
|
EXF001 |
Exfoliation Syndrome |
55 |
0.041 |
|
171 |
|
|
THR004 |
Thrombocytosis |
55 |
0.041 |
|
172 |
|
c
|
MCR113 |
Microvascular Complications of Diabetes 3 |
55 |
0.041 |
|
173 |
|
P
|
HYP750 |
Hypertriglyceridemia, Familial |
55 |
0.041 |
|
174 |
|
|
TTH006 |
Tooth Disease |
54 |
0.041 |
|
175 |
|
|
HMZ003 |
Homozygous Familial Hypercholesterolemia |
54 |
0.041 |
|
176 |
|
P
|
HYP818 |
Hypobetalipoproteinemia, Familial, 1 |
54 |
0.041 |
|
177 |
|
P
|
FNC004 |
Fanconi Syndrome |
54 |
0.041 |
|
178 |
|
|
SCK005 |
Sickle Cell Disease |
54 |
0.041 |
|
179 |
|
|
DNY001 |
Denys-Drash Syndrome |
54 |
0.041 |
|
180 |
|
|
RST001 |
Restless Legs Syndrome |
54 |
0.041 |
|
181 |
|
|
GST027 |
Gastric Lymphoma |
53 |
0.041 |
|
182 |
|
|
OVR063 |
Overnutrition |
53 |
0.041 |
|
183 |
|
|
HYD058 |
Hydrops, Lactic Acidosis, and Sideroblastic Anemia |
53 |
0.041 |
|
184 |
|
|
XNT003 |
Xanthomatosis |
53 |
0.041 |
|
185 |
|
|
HMG005 |
Hemoglobinopathy |
53 |
0.041 |
|
186 |
|
|
ENT011 |
Enterocolitis |
52 |
0.041 |
|
187 |
|
|
HYP732 |
Hyperalphalipoproteinemia 1 |
52 |
0.041 |
|
188 |
|
|
HPT082 |
Hepatic Adenomas, Familial |
52 |
0.041 |
|
189 |
|
|
HMG002 |
Hemoglobinuria |
52 |
0.041 |
|
190 |
|
P
|
RNL007 |
Renal Tubular Acidosis |
51 |
0.041 |
|
191 |
|
|
ART140 |
Arteries, Anomalies of |
51 |
0.041 |
|
192 |
|
c
|
HYP739 |
Hyperlipoproteinemia, Type Iv |
51 |
0.041 |
|
193 |
|
|
INT067 |
Interstitial Nephritis |
51 |
0.041 |
|
194 |
|
c
|
DWL002 |
Dowling-Degos Disease 1 |
50 |
0.041 |
|
195 |
|
c
|
WLM018 |
Wilms Tumor 5 |
49 |
0.041 |
|
196 |
|
P
|
AFB001 |
Afibrinogenemia |
49 |
0.041 |
|
197 |
|
|
HYP081 |
Hypolipoproteinemia |
49 |
0.041 |
|
198 |
|
P
|
FML035 |
Familial Hyperlipidemia |
48 |
0.041 |
|
199 |
|
c
|
AMY009 |
Amyloidosis Aa |
48 |
0.041 |
|
200 |
|
|
ART004 |
Aortic Atherosclerosis |
48 |
0.041 |
|
201 |
|
|
NSS002 |
Neisseria Meningitidis Infection |
47 |
0.041 |
|
202 |
|
|
AMY082 |
Amyloidosis, Familial Visceral |
47 |
0.041 |
|
203 |
|
|
PST011 |
Pustulosis of Palm and Sole |
47 |
0.041 |
|
204 |
|
|
NPH010 |
Nephrosclerosis |
46 |
0.041 |
|
205 |
|
|
PLC003 |
Placental Site Trophoblastic Tumor |
46 |
0.041 |
|
206 |
|
|
FTL021 |
Fetal Macrosomia |
46 |
0.041 |
|
207 |
|
P
|
HRD009 |
Hereditary Wilms' Tumor |
46 |
0.041 |
|
208 |
|
|
NTR003 |
Natural Killer Cell Leukemia |
45 |
0.041 |
|
209 |
|
|
FSH001 |
Fish-Eye Disease |
45 |
0.041 |
|
210 |
|
P
|
ANL018 |
Analbuminemia |
45 |
0.041 |
|
211 |
|
c
|
LKD015 |
Leukodystrophy, Hypomyelinating, 3 |
44 |
0.041 |
|
212 |
|
|
CRS001 |
Crescentic Glomerulonephritis |
44 |
0.041 |
|
213 |
|
c
|
WLM011 |
Wilms Tumor 6 |
44 |
0.041 |
|
214 |
|
|
MCR225 |
Macrophage Activation Syndrome |
44 |
0.041 |
|
215 |
|
|
SCH076 |
Schnyder Corneal Dystrophy |
44 |
0.041 |
|
216 |
|
c
|
HYP734 |
Hypercholesterolemia, Autosomal Dominant, Type B |
44 |
0.041 |
|
217 |
|
|
SBL008 |
Sea-Blue Histiocyte Disease |
43 |
0.041 |
|
218 |
|
|
NRN002 |
Neuronitis |
43 |
0.041 |
|
219 |
|
|
IMM106 |
Immunodysregulation, Polyendocrinopathy, and Enteropathy, X-Linked |
43 |
0.041 |
|
220 |
|
c
|
MCR130 |
Microvascular Complications of Diabetes 6 |
42 |
0.041 |
|
221 |
|
|
BRR012 |
Berardinelli-Seip Congenital Lipodystrophy |
42 |
0.041 |
|
222 |
|
|
CMP009 |
Complement Deficiency |
41 |
0.041 |
|
223 |
|
|
CMP004 |
Complement Factor I Deficiency |
41 |
0.041 |
|
224 |
|
|
CRB009 |
Cerebritis |
41 |
0.041 |
|
225 |
|
|
LYM029 |
Lymphedema-Distichiasis Syndrome |
41 |
0.041 |
|
226 |
|
c
|
FBR046 |
Fibrosis of Extraocular Muscles, Congenital, 1 |
40 |
0.041 |
|
227 |
|
|
CMP080 |
Complement Hyperactivation, Angiopathic Thrombosis, and Protein-Losing Enteropathy |
40 |
0.041 |
|
228 |
|
c
|
HRD088 |
Hereditary Neuropathies |
40 |
0.041 |
|
229 |
|
|
ARC023 |
Arcus Corneae |
40 |
0.041 |
|
230 |
|
c
|
PSR017 |
Psoriasis 2 |
40 |
0.041 |
|
231 |
|
|
IMM001 |
Immune-Complex Glomerulonephritis |
39 |
0.041 |
|
232 |
|
|
RTR010 |
Retroperitoneal Sarcoma |
39 |
0.041 |
|
233 |
|
|
XNT009 |
Xanthoma Disseminatum |
38 |
0.041 |
|
234 |
|
c
|
PSR028 |
Psoriasis 7 |
37 |
0.041 |
|
235 |
|
|
FML330 |
Familial Lcat Deficiency |
37 |
0.041 |
|
236 |
|
c
|
LKM004 |
Leukemia, B-Cell, Chronic |
37 |
0.041 |
|
237 |
|
|
DFF021 |
Diffuse Mesangial Sclerosis |
36 |
0.041 |
|
238 |
|
|
TRC109 |
Tracheoesophageal Fistula with or Without Esophageal Atresia |
36 |
0.041 |
|
239 |
|
|
LSS001 |
Loiasis |
36 |
0.041 |
|
240 |
|
c
|
LKM056 |
Leukemia, Chronic Lymphocytic 2 |
35 |
0.041 |
|
241 |
|
c
|
PSR032 |
Psoriasis 11 |
35 |
0.041 |
|
242 |
|
|
SPN331 |
Spondyloocular Syndrome |
34 |
0.041 |
|
243 |
|
c
|
MCR120 |
Microvascular Complications of Diabetes 7 |
34 |
0.041 |
|
244 |
|
|
DGN003 |
Degeneration of Macula and Posterior Pole |
32 |
0.041 |
|
245 |
|
c
|
MCR133 |
Microvascular Complications of Diabetes 4 |
32 |
0.041 |
|
246 |
|
|
DFC001 |
Defective Apolipoprotein B-100 |
31 |
0.041 |
|
247 |
|
|
LCR013 |
Lacrimal Duct Defect |
31 |
0.041 |
|
248 |
|
|
ATM052 |
Autoimmune Disease 1 |
30 |
0.041 |
|
249 |
|
|
RTN006 |
Retinal Drusen |
29 |
0.041 |
|
250 |
|
|
EPL199 |
Epilepsy, Progressive Myoclonic, 4, with or Without Renal Failure |
28 |
0.041 |
|
251 |
|
|
UND007 |
Undifferentiated Connective Tissue Disease |
28 |
0.041 |
|
252 |
|
c
|
BKV001 |
Bk-Virus Nephropathy |
26 |
0.041 |
|
253 |
|
|
DFF031 |
Diffuse Alveolar Hemorrhage |
25 |
0.041 |
|
254 |
|
P
|
FTT008 |
Fatty Liver Disease, Nonalcoholic 1 |
25 |
0.041 |
|
255 |
|
|
CMP064 |
Complement Component 3 Deficiency |
23 |
0.041 |
|
256 |
|
|
LGP003 |
Logopenic Progressive Aphasia |
23 |
0.041 |
|
257 |
|
c
|
FCL082 |
Focal Segmental Glomerulosclerosis 4 |
22 |
0.041 |
|
258 |
|
|
IMM162 |
Immunoglobulin E Concentration, Serum |
16 |
0.041 |
|
259 |
|
|
DNS001 |
Dense Deposit Disease/membranoproliferative Glomerulonephritis Type Ii |
6 |
0.041 |
|